Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs (Q32063802)

6 July 2017

Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs (English)

1 reference

6 July 2017

5

Pasternak GW

1 reference

6 July 2017

King M

1

1 reference

6 July 2017

Su W

series ordinal

2

1 reference

6 July 2017

Chang A

series ordinal

3

1 reference

6 July 2017

Zuckerman A

series ordinal

4

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

6 July 2017

1 reference

6 July 2017

4

1 reference

6 July 2017

3

1 reference

6 July 2017

268-274

1 reference

Elevation of tumor necrosis factor in head injury.

6 July 2017

1 reference

7 January 2021

Saturable transport of peptides across the blood-brain barrier

1 reference

7 January 2021

Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.

1 reference

7 January 2021

Passage of peptides across the blood-brain barrier: pathophysiological perspectives

1 reference

7 January 2021

Increased brain P-glycoprotein in morphine tolerant rats

1 reference

7 January 2021

Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation

1 reference

7 January 2021

Transport of the delta-opioid receptor agonist [D-penicillamine2,5] enkephalin across the blood-brain barrier involves transcytosis1.

1 reference

7 January 2021

Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug

1 reference

7 January 2021

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

7 January 2021

The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice.

1 reference

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

7 January 2021

P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain

1 reference

7 January 2021

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

7 January 2021

Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein

1 reference

7 January 2021

Multidrug resistance and the role of P-glycoprotein knockout mice

1 reference

7 January 2021

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

1 reference

7 January 2021

Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells.

1 reference

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

7 January 2021

Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression.

1 reference

7 January 2021

Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance

1 reference

7 January 2021

Antisense to MDR1 mRNA reduces P-glycoprotein expression, swelling-activated C1- current and volume regulation in bovine ciliary epithelial cells.

1 reference

7 January 2021

Genetic analysis of the multidrug transporter

1 reference

7 January 2021

Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites.

1 reference

7 January 2021

Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain

1 reference

7 January 2021

Dissociation of affinity and efficacy in KOR-3 chimeras

1 reference

7 January 2021

Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla

1 reference

7 January 2021

Synergistic brainstem interactions for morphine analgesia

1 reference

7 January 2021

Dissociation of morphine's analgesic and respiratory depressant actions

1 reference

7 January 2021

The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine

1 reference

7 January 2021

Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.

1 reference

7 January 2021

Spinal analgesic activity of orphanin FQ/nociceptin and its fragments

1 reference

7 January 2021

Peripheral blockade of topical morphine tolerance by ketamine.

1 reference

7 January 2021

Identifiers

DOI

10.1038/85115

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference